Ahmedabad based contract research and manufacturing services (CRAMS) major Dishman Pharmaceuticals and Chemicals Ltd has posted a 30 percent erosion in its profit after tax(PAT) for the quarter ended June 30, on the back of a dip in sales.
The consolidated turnover of the company stood at '201.88 crore, down by 11 per cent from '227.21 crore in the same period last fiscal.
The company said in a statement that the current quarter’s profits include forex gain of '10.05 crore in contrast to previous fiscal’s '15.10 crore forex gains.
